WazaGaY: An Innovative Aza-BODIPY-Derived Near-Infrared Fluorescent Probe for Enhanced Tumor Imaging
Journal of Medicinal Chemistry · 26.09.2024 · 67 (18) · 16635-16648
DOI: 10.1021/acs.jmedchem.4c01435 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 17.09.2024. Verfasst von Mohamed Bendellaa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences (IAB), Grenoble 38000, France. Hauptthemen laut MEDLINE: Fluorescent Dyes, Boron Compounds. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Agence Nationale de la Recherche, Groupement des Entreprises Fran?aises dans la lutte contre le Cancer, Minist?re de l'Enseignement Sup?rieur et de la Recherche Scientifique.
Abstract (Originalsprache)
Aza-BODIPYs represent a class of fluorophores in which the π-conjugated system is rigidified and stabilized by a boron atom. A promising strategy to enhance their fluorescence properties involves replacing the boron atom with a metal ion. Here, we describe the synthesis and characterization of a water-soluble derivative where the metal is a gallium(III) ion, termed WazaGaY (water-soluble aza-GaDIPY). Water solubility is ensured by two ammonium substituents, inducing a bathochromic shift and a significant increase in quantum yield compared to that of the dimethylamino analog. The cellular behavior of WazaGaY-1 was observed across different tumor cells. In vivo, the distribution and safety profiles were determined, and tumor uptake was assessed in various tumor types. Following intravenous injection, WazaGaY-1 enabled clear discrimination of tumors engrafted subcutaneously in mice with high tumor-to-muscle ratios (ranging from 7 to 20), even in the absence of specific conjugation. Its potential as a contrast agent for fluorescence-guided surgery was confirmed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences (IAB), Grenoble 38000, France.
- Institut de Chimie Moléculaire de l'Université de Bourgogne, Université de Bourgogne, CNRS UMR 6302, Dijon 21078, France.
- CNRS, ENS de Lyon, CNRS, LCH, UMR 5182, Lyon F-69342, France.
- Nantes Université, CNRS, CEISAM, UMR 6230, Nantes F-44000, France.
- Institut Universitaire de France (IUF), Paris 75005, France.
- Grenoble Alpes University Hospital (CHUGA), Grenoble 38043, France.
ORCID-Profile: Annika Sickinger, Christine Goze, Olivier Maury, Pierre Le Gendre, Ewen Bodio, Benoit Busser, Lucie Sancey
Förderung
- Agence Nationale de la Recherche
- Groupement des Entreprises Fran?aises dans la lutte contre le Cancer
- Minist?re de l'Enseignement Sup?rieur et de la Recherche Scientifique
- Ligue Contre le Cancer
- Centre National de la Recherche Scientifique
- Conseil r?gional de Bourgogne-Franche-Comt?
- SATT Linksium
- Comit? de l?Is?re
Zitieren
APA
Bendellaa, M., Cave, C., Godard, A., Dalonneau, F., Sickinger, A., Goze, C., Maury, O., Le Gendre, P., Bodio, E., Busser, B., & Sancey, L. (2024). WazaGaY: An Innovative Aza-BODIPY-Derived Near-Infrared Fluorescent Probe for Enhanced Tumor Imaging. Journal of Medicinal Chemistry, 67(18), 16635-16648. https://doi.org/10.1021/acs.jmedchem.4c01435
Vancouver
Bendellaa M, Cave C, Godard A, Dalonneau F, Sickinger A, Goze C, et al. WazaGaY: An Innovative Aza-BODIPY-Derived Near-Infrared Fluorescent Probe for Enhanced Tumor Imaging. Journal of Medicinal Chemistry. 2024;67(18):16635-16648. doi:10.1021/acs.jmedchem.4c01435
BibTeX
@article{Bendellaa2024,
author = {Bendellaa, Mohamed and Cave, Charlotte and Godard, Amélie and Dalonneau, Fabien and Sickinger, Annika and Goze, Christine and Maury, Olivier and Le Gendre, Pierre and Bodio, Ewen and Busser, Benoit and Sancey, Lucie},
title = {WazaGaY: An Innovative Aza-BODIPY-Derived Near-Infrared Fluorescent Probe for Enhanced Tumor Imaging},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
number = {18},
pages = {16635--16648},
doi = {10.1021/acs.jmedchem.4c01435}
}
EUVIMED